Novavax, Inc. is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on drug delivery and biological technologies.
Welcome to future generation products on bionanotechnology at Velbionanotech(VBN)
established in March 2002, This was set up to promote Research & Development
worldwide, making use of...
Article - 23 Aug 2006
The very slow progress in the treatment of severe diseases has led to the adoption of a multidisciplinary approach to the targeted delivery and release of drugs, underpinned by nanoscience and...
News - 20 Jul 2009
Proton therapy -- which uses beams of the subatomic particles to treat cancer -- is a hot topic at this year's American Association of Physicists in Medicine (AAPM) meeting, which takes place from...
Article - 13 Dec 2004
The medical and pharmaceuticals sector will benefit from advances in nanotechnology, with diagnostics, drugs delivery and tissue regeneration being three of the main areas of development. This article...
News - 15 Feb 2013
Applied Spectral Imaging announced today that its GenASIs Scan & Analysis automated microscopy platform has received FDA clearance as an aid in ALK gene analysis for lung cancer therapy selection....
News - 17 Jun 2008
NanoViricides, Inc., said that its lead anti-HIV drug candidate demonstrated markedly superior survival results in the test animals when compared to those animals given the anti-HIV "combo...
News - 3 Aug 2011
According to Eugene Seymou, who serves as Chief Executive Officer at NanoViricides, a company developing unique nanomaterials for viral therapy, the company plans to improve its HIVCide candidate...
News - 31 Jan 2014
Research and Markets has announced the addition of a new report "Antiviral Therapeutics - Technologies, Markets and Companies" to their offering.
This report reviews the current...
News - 3 May 2013
Research and Markets has announced the addition of Jain PharmaBiotech's new report "Antiviral Therapeutics - Technologies, Markets and Companies" to their offering.